Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Paul Thompson MD
Paul D. Thompson MD Advisory Board
James Udelson MD
James E. Udelson MD Advisory Board
Anne Valente MD
Anne Marie Valente MD Advisory Board
See All Experts
story of the week
Published in Cardiology

Journal Scan / Research · August 13, 2015

Elevated Plasma B-Type Natriuretic Peptide Inhibits Neprilysin Activity in Heart Failure

JACC: Heart Failure

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Douglas Mann MD

JACC: Heart Failure
Elevated Plasma B-Type Natriuretic Peptide Concentrations Directly Inhibit Circulating Neprilysin Activity in Heart Failure
JACC Heart Fail 2015 Aug 01;3(8)629-636, N Vodovar, MF Séronde, S Laribi, E Gayat, J Lassus, JL Januzzi, R Boukef, S Nouira, P Manivet, JL Samuel, D Logeart, A Cohen-Solal, AM Richards, JM Launay, A Mebazaa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated